Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on the stock and raised its price target from $35 to $41. RxSight shares jumped 20% to $44.31 on Monday. Here are some other stocks moving in today’s mid-day session. GainersHarpoon Therapeutics, Inc. (NASDAQ: HARP) shares jumped 111.2% to $22.28 after Merck announced it will acquire the company for $23 per share in cash.Ambrx Biopharma Inc. (NASDAQ: AMAM) jumped 98.1% to $27.00 after Johnson & Joh…
